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Background: Black women have the highest prevalence of hypertension in the world. Rea-
sons for this disparity are poorly understood.The historical legacy of medical maltreatment
of Blacks in the U.S. provides some insight into distrust in the medical profession, refusal
of treatment, and poor adherence to treatment regimens.
Methods: Black women (N =80) who were prescribed antihypertensive medications were
recruited from urban communities in North Carolina. Study participants completed theTrust
in Physician and Hill-Bone Compliance to High Blood Pressure Therapy questionnaires.
An exact discrete-event model was used to examine the relationship between trust and
medication adherence.
Results: Mean age of study participants was 48±9.2 years. The majority of participants
(67%) were actively employed and 30% had incomes at or below the federal poverty level.
Increasing levels of trust in the health care provider was independently associated with
greater medication adherence (PTrend=0.015).
Conclusion: Black women with hypertension who trusted their health care providers were
more likely to be adherent with their prescribed antihypertensive medications than those
who did not trust their health care providers. Findings suggest that trusting relationships
between Black women and health care providers are important to decreasing disparate
rates of hypertension.
Keywords: trust, medication adherence, Black women, hypertension, health care provider
INTRODUCTION
Mutual trust is essential to the patient/heath care provider rela-
tionship and the achievement of positive health outcomes. To be
trustworthy, health care providers need to show competence, car-
ing behaviors, good interpersonal skills, and a desire to promote
the health of the patients they serve (1, 2). Likewise, trustworthy
patients need to be honest, adhere to the treatment regimen, and
perform self-care behaviors (2). Trust is not assumed, but it can
be earned over time as the patient and health care provider get
to know each other by working together to ensure that accurate
medical conclusions are obtained and the best course of treat-
ment is determined and executed (1). Similarly, a patient’s trust
in the health care provider implies confidence that their words are
truthful and actions are appropriate in the provision of care and
treatment (1). When health care providers trust their patients, it
implies a belief that the patient will seek timely health care, reveal
sensitive information, and follow the recommended treatment
regimen (1).
The historical legacy of Blacks in the U.S. provides insight
as to why distrust in the medical profession exists. Introduced
to the U.S. as slaves, Blacks had little to no human rights. Fre-
quently, they were used in experiments by White doctors to perfect
medical and surgical techniques before attempting procedures on
Whites (3–5). Because of skin color and other distinctive fea-
tures such as hair texture, thick lips, and body shape, the lives
of Blacks were not valued, and their exploitation by White physi-
cians endured a long history (3–5). Myths were invented by the
medical community to portray Blacks as different, inferior, and
less than human. These myths resulted in the enactment of laws in
the U.S. that distinguished Black people as property on the same
level with livestock and beast of burden (5, 6). Published journal
articles and doctors records on various types of medical exper-
imentation with Blacks spanned several centuries. Examples of
experiments included: unanesthetized gynecological experiments
on slave women; Tuskegee syphilis study that withheld treatment
to plot disease progress in men; eugenic-inspired involuntary ster-
ilizations of welfare mothers with multiple children; unconsented
high dose radiation experiments; and hazardous dermatological
research on prison subjects (4).
Present treatment related issues also influence distrustful rela-
tionships between Blacks and health care providers. In the land-
mark Institute of Medicine report (7, 8), research indicated that
minority/ethnic groups are less likely than Whites to receive
needed services, procedures, and routine treatments for common
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health problems and for diseases such as cancer, cardiovascular dis-
ease, and diabetes. In cardiac care for example, minorities are less
likely to receive pharmacological therapy, transplants, catheteriza-
tion, and bypass surgery even when treatments and procedures are
judged to be appropriate (7, 8). In contrast, they are more likely
to receive lower quality care and undesirable procedures such as
lower extremity amputations for diabetes. Equally perplexing is
the strong link related to finances and access to cardiac care (9)
that often results in discriminatory practices for poor people. It is
also daunting to consider that discriminatory practices persist even
in Blacks and other minority/ethnic groups who have the ability
to pay for health care services (10). Thus, the maltreatment expe-
rienced by Blacks in the health care arena contributes not only
to distrust, but also refusal of treatment and poor adherence to
treatment regimens (3, 7). Today, remnants of history continue in
subtle configurations resulting in many Blacks approaching health
care with fear, skepticism, and caution (3).
Currently, disparate rates of heart disease, kidney disease, and
stroke associated with uncontrolled hypertension (HTN) in Blacks
who reside in the U.S are perplexing. When the prevalence of
HTN is delineated by race and sex, HTN is greater for Black
women (47%), followed by Black men (43%), then White men
(33%) and White women (31%), and is lowest for Hispanic men
(30%) and women (29%) (11). These statistics are especially con-
cerning because Black women are cited as having the highest
prevalence of HTN in the U.S. and worldwide, and rates are
increasing (11). Thus, alleviating sources that potentiate non-
adherence to treatment regimens such as medication adherence
is important. One factor, mistrust in health care providers among
Black women with hypertension may potentially lead to poorer
medication adherence. To our knowledge, no studies have exam-
ined the association of trust and adherence to antihypertensive
medications in an exclusively Black female population. There-
fore, this study examined the association between trust in health
care providers and medication adherence among these Black
women.
MATERIALS AND METHODS
STUDY SAMPLE
A cross-sectional pilot study was conducted with hypertensive
Black women in the Piedmont region of North Carolina. Methods
used in this study have been reported elsewhere and are briefly
described here (12). Inclusion criteria included (a) ages ranging
from 18 to 60 years, (b) taking one or more prescription med-
ication(s) for HTN, and (c) English speaking. Exclusion criteria
included self-report of (a) mental illness that interfered with daily
functioning, (b) current pregnancy, or (c) concurrent participa-
tion in another research study. Using an a priori adaptive algorithm
to compute power, a sample size of 80 was required to detect an
effect size of 4.5 (alpha of 0.05) with power of 80.9%, assuming a
referent event rate of 0.4 (13). Recruitment efforts included dis-
tributing flyers to various Black communities and businesses such
as hair salons, churches, and community events, along with social
nomination. Informed consent was obtained from all participants
who met eligibility criteria and agreed to participate in the study.
Data were collected in a private setting to ensure participant pri-
vacy. Questionnaires were generally completed in a 1-hour session.
Approval was obtained from the Institutional review board at the
University of North Carolina at Greensboro.
MEASURES
Standardized instruments were used to gather information on
medication adherence and trust in the health care provider among
study participants. Demographic data (e.g., education, income,
medical history, etc.) and anthropometric measurements (e.g.,
blood pressure, height, weight, and waist circumference) also were
collected.
Trust in Physician Scale
The Trust in Physician Scale (TPS) is an 11-item tool that measures
patient trust in their physician (14). In the current study, the word
“physician”was replaced with“health care provider”because of the
likelihood that patients would be seen by mid-level providers such
as nurse practitioners or physician assistants. Responses on the
TPS are scored on a five-point Likert scale from 1 (strongly agree)
to 5 (strongly disagree). “Neutral” was not used as a response
item. This was done in an effort to force participants to express
their opinion to specific responses because neutral data would not
provide meaningful information. Scores can range from 11 to 55
with higher scores indicating greater trust. Four items are reverse
scored to prevent repetitive responses. Cronbach’s alphas for the
TPS ranged from 0.85 to 0.90 in a previous study (14) and alpha
was 0.835 for this study.
Hill-Bone Compliance to High Blood Pressure Therapy Scale
The Hill-Bone Compliance to High Blood Pressure Therapy Scale
(CHBPTS) is a 14-item tool used to assess antihypertensive med-
ication adherence and has been reported elsewhere (12). In this
study, “compliance” was replaced by “adherence” because of the
passivity associated with the word “compliance” that hinders the
establishment of a working relationship with the person (15, 16).
Included in the Hill-Bone CHBPTS is the four-item Medication
Adherence Scale (MMAS) developed by Morisky et al. (17, 18).
The Hill-Bone CHBPTS includes three subscales, and for this
study only the medication subscale (eight items) was chosen to
assess medication-taking behavior plus one item that addressed
prescription refills. Responses are scored on a four-point Likert
scale from 1 (“none of the time”) to 4 (“all the time”). The min-
imal medication-taking score is 9 and the maximum score is 36.
Lower scores reflect medication adherence behaviors and higher
scores represent non-adherence. Cronbach’s alpha for the medica-
tion subscale was 0.77 in a previous study (19) and alpha was 0.843
for this study.
DATA ANALYSIS
Descriptive statistics were used to characterize the sample and
study tools. Cronbach’s alpha measured internal reliability of the
instruments and a consistency of 0.70 or higher are considered
acceptable and values of 0.60 or higher are marginally accept-
able (20). The exact discrete-event (proportional odds) model is a
log-linear procedure that is especially suited for analyzing ordinal
outcomes with non-normally distributed error terms (21). Rela-
tive importance scores (RIS), denoting the proportional odds of
a higher (or lower) outcome score for a specific level of a pre-
dictor variable compared with referent group, were computed
Frontiers in Public Health | Epidemiology December 2013 | Volume 1 | Article 66 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abel and Efird Trust and medication adherence
using this model. P values for linear trend across levels of a
predictor variable were computed using a likelihood ratio test.
Variables were included in the optimal predictive model if, for at
least one level of a predictor variable, p< 0.025 and RIS >2.5 or
RIS <0.4. The post hoc addition of other variables into the final
model was determined in a systematic, pairwise fashion, based
upon a 10% increase or decrease in the magnitude of levels for
the main effect variable (e.g., trust in the health care provider).
All statistics were computed using SAS version 9.3 (Cary, NC,
USA).
RESULTS
Participants in the sample ranged in age from 19 to 60 years,
with the majority aged 50 or older. Approximately 68% were not
married, 33% were unemployed or retired, and over 70% were
obese. A total of 84% had completed high school or a higher
level of education (see Table 1). The duration of antihyperten-
sive medication treatment for participants ranged from 1 month
to 37 years (mean 10.2± SD 8.6, median 10). Of the 20 partici-
pants who claimed complete adherence to their antihypertensive
medications, the majority were in the 50–60 age group (n= 12).
The instruments used in the study had acceptable internal reliabil-
ity (Cronbach’s alpha ≥60%). The median score for participant’s
trust in their primary health care provider was above the mean of
possible values (mean 43.9± SD 6.3, median 45.0), with a score
of 55 indicating perfect trust. The median score for participant’s
adherence to antihypertensive medication was below the mean of
possible values (mean 13.1± SD 4.2, median 12.5), with a score of
9 indicating perfect adherence.
Three univariable variables that predicted medication adher-
ence were participant age, number of medications, and trust
in health care provider (see Table 2). All age groups (Q2–Q4)
were less likely to be adherent but participants in the 40–49 age
group (Q3) had the highest RIS score and were 3.6 fold less
likely to be adherent to antihypertensive medications than base-
line (Q1) (P for trend= 0.028). In contrast participants who
reported taking five to seven medications (Q3) were 3.8 fold
more likely to be adherent than baseline (Q1) (p= 0.001). How-
ever, a significant linear trend was not observed for “number
of medications.” The third univariable variable that predicted
medication adherence was trust in health care provider. Partic-
ipants who scored in the highest trust group Q4 (>52) were
16.7 fold more likely to be adherent than baseline (Q1) (P for
trend= 0.010).
Variables retained in the “optimal predictive model” included
participant age, number of medications, and trust in health care
provider (see Table 2). Again all age groups were less likely to
be adherent, but participants in the 40–49 age group (Q3) had
the highest RIS score and were 3.7 fold less likely to be adher-
ent to antihypertensive medications than baseline (Q1) (P for
trend= 0.0036). Whereas participants who reported taking five to
seven medications (Q3) were 3.6 fold more likely to be adherent
than baseline (Q1) (p= 0.0048). However, similar to the univari-
able case, a significant linear trend was not observed for “number
of medications.”Participants who scored in the highest trust group
Q4 (>52) were 33.3 fold more likely to be adherent than baseline
(Q1) (P for trend= 0.015).
Table 1 | Sample characteristics and demographics (N =80).
Characteristics N (%) or mean (±SD)
Age 47.8 (±9.2)
Marital status
Single (never married) 22 (28)
Married 26 (33)
Separated 9 (11)
Divorced 16 (20)
Widowed 7 (9)
Employment status
Employed 54 (68)
Unemployed/disabled 24 (30)
Retired 2 (3)
Comorbidities 2.8 (±1.6)
Number of medications 5.1 (±3.6)
BP
SBP mean 135.2 (±19.8)
DBP mean 81.3 (±12.6)
BMI 36.8 (±10.4)
Subscales
Underweight (<18.5 kg/m2) 1 (1)
Normal weight (18.5–24.9 kg/m2) 9 (11)
Overweight (25–29.9 kg/m2) 10 (13)
Obesity (≥30 kg/m2) 60 (75)
Education
Less than 12th grade 13 (16)
High school graduate 16 (20)
GED or equivalent 1 (1)
Some community college 11 (14)
Graduated community college 6 (8)
Some 4-year college 5 (6)
Graduated 4-year college 10 (13)
Some graduate school 2 (3)
Completed graduate school 6 (8)
Completed trade or vocational school 10 (13)
Income
<$10,000 15 (19)
$10,000–14,999 4 (5)
$15,000–19,999 10 (13)
$20,000–24,999 8 (10)
$25,000–$34,999 10 (13)
$35,000–$44,999 12 (15)
$45,000–54,999 6 (8)
$55,000–64,999 6 (8)
$65,000–74,999 3 (4)
$75,000–$99,999 3 (4)
$100,000 and over 2 (3)
Refused 1 (1)
Percentages rounded.
BP=blood pressure; SBP= systolic blood pressure; DBP=diastolic blood pres-
sure; BMI=body mass index.
www.frontiersin.org December 2013 | Volume 1 | Article 66 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abel and Efird Trust and medication adherence
Table 2 | Exact discrete-event model for compliance scale (range=9–33).¶
Characteristics Univariable predictors Optimal predictive model
Crude RIS 95% CI Adjusted RIS 95% CI
Trust in primary health care provider
Q1 (<41) (Low) 1.0 Referent 1.0 Referent
Q2 (41–45) 0.86 0.44–1.7 (p=0.66) 0.84 0.40–1.8 (p=0.65)
Q3 (46–52) 0.57 0.28–1.2 (p=0.12) 0.64 0.29–1.4 (p=0.26)
Q4 (>52) (high) 0.06 0.01–0.39 (p=0.003) 0.03 0.004–0.23 (p=0.0006)
PTrend=0.010§ PTrend=0.015§
Patient age (years)
Q1 (>55) 1.0 Referent 1.0 Referent
Q2 (50–55) 2.3 1.1–4.9 (p=0.029) 2.9 1.3–6.5 (p=0.011)
Q3 (40–49) 3.6 1.6–8.0 (p=0.001) 3.7 1.6–8.6 (p=0.0028)
Q4 (<40) 2.4 1.02–5.4 (p=0.044) 3.2 1.3–8.2 (p=0.013)
PTrend=0.028§ PTrend=0.0036§
No. of medications
Q1 (1–2) 1.0 Referent 1.0 Referent
Q2 (3–4) 0.56 0.28–1.1 (p=0.11) 0.47 0.22–0.99 (p=0.047)
Q3 (5–7) 0.26 0.12–0.59 (p=0.001) 0.28 0.12–0.68 (p=0.0048)
Q4 (8–18) 0.65 0.31–1.4 (p=0.25) 0.73 0.34–1.6 (p=0.45)
PTrend=0.11§ PTrend=0.35§
¶Lower scores reflect medication adherent behaviors and higher scores reflect non-adherent behaviors. §Likelihood ratio trend test. RIS=Relative Importance Score;
CI= confidence intervals; Q=quartile.
Thus, increasing levels of trust in the health care provider was
associated with greater medication adherence (optimal predic-
tive model; Q1: RIS= 1.0; Q2: RIS= 0.84, 95% CI= 0.40–1.8; Q3:
RIS= 0.64, 95% CI= 0.29–1.4; Q4: RIS= 0.03, 95% CI= 0.004–
0.23; PTrend= 0.015), independent of age and number of med-
ications (see Table 2). In summary, participant age was the
variable that independently predicted non-adherence to antihy-
pertensive medications and trust was the only variable that inde-
pendently predicted adherence to antihypertensive medications in
our “optimal predictive model.”
DISCUSSION
To date, studies on trust and medication adherence have been con-
ducted primarily with Black men (22). Other studies have included
both Black and White men and women but did not specifically
target Black females (23). The current study represents the first to
examine the association between trust and medication adherence
in an exclusively Black female population.
Several studies have cited distrust of the medical community
as the rationale for non-adherent health behaviors (2, 24–26).
Blacks often mention the Tuskegee experiments and medical injus-
tices experienced personally or by family members and friends.
These injustices, along with issues such as racism, discrimination,
access to care, financial barriers, thoughts of being experimented
on, and substandard health care affect the ability of Blacks to
trust the medical community (2). Consequently, many Blacks
are reluctant to seek health care or follow medical advice result-
ing in non-adherence to the treatment regimen and subsequent
health problems (2, 26–28). Thus, antihypertensive medication
non-adherence, is likely to result in poor blood pressure control
with greater organ damage such as heart failure, kidney disease,
myocardial infarction, and stroke (11).
In the current study, all age groups were less likely to be adherent
to their antihypertensive medications, but the greatest predictor
was participants aged 40–49. These findings differ from those
of other studies. For example, Schoenthaler et al. (29) reported
that younger Blacks exhibited more non-adherent medication
behaviors. In addition, Weingarten and Cannon (30) reported
lower adherence to antihypertensive medications among those
younger than age 55 and older than age 65. A higher percent-
age of participants over age 50 in our study indicated medication
adherence compared to those less that age 50. One explana-
tion for less adherence to antihypertensive medications among
those aged 40–49 could be the stressors of marriage, working,
and family responsibilities because women at this age are more
likely to be married or separated, work full- or part-time, and
live in households with more people than those in the other age
groups.
Furthermore, participants in our study who took five to seven
medications were more likely to be adherent to their medication
regimen. This finding was not consistent with the literature which
reports that fewer medications equate to better adherence (31,
32). Perhaps those with a higher number of medications per-
ceived themselves as sicker and were therefore more adherent. Also,
the increased number of medications may have serendipitously
contributed to frequent visits to the health care provider that fos-
tered better communication, trust, and engagement in self-care
and medication adherence.
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Participants in this study who reported the most trust in their
health care providers were more adherent to their prescribed anti-
hypertensive medications. This finding is consistent with the view
that trust promotes better medication adherence (29, 33). Nguyen
et al. (34) used the same instruments to measure trust and medica-
tion adherence as those used in the current study and found that
higher adherence was associated with greater trust in the health
care provider in participants with inflammatory bowel disease
(IBO). One major difference between the two diagnostic groups
that may influence adherence is that IBO has symptoms and HTN
is silent.
The issue of poor adherence in Black women with HTN is
multifactorial and complicated by cultural,psychosocial, socioeco-
nomic, environmental, physiological, and genetic influences (35).
Health care providers need to understand how these processes
influence the health and behaviors of patients and potentially
simulate rebellion, conflict, and mistrust in relationships with
providers (36). The enormity of the multifaceted and ubiquitous
nature of adherence sheds light on the limited success of adher-
ence research and interventions. Therefore it is vital that health
care providers devise strategies to alter the processes and systems
that influence the health status of individuals and populations
and empower groups and individuals to work on their own behalf
(36). Thus, future research aimed at involving the patient as a
participant in their health care may be a key factor to devising
strategies that influence the multifaceted nature of non-adherence
and mistrust of health care providers.
Interestingly, it is well documented that antihypertensive med-
ications have proven efficacy in lowering blood pressure when
patients adhere to the treatment regimen (37–40). However, many
Black women have not readily participated in risk reduction
behaviors to manage and prevent HTN (41–43). One possible
explanation for the lack of adherence to treatment regimens may
be attributed to the effect that past medical injustices have on
present health behaviors. Distrust in health care providers is a
potential barrier to medication adherence among Black women
with hypertension. Our study found that increased trust was asso-
ciated with greater medication adherence. Thus, it is important
that health care providers and Blacks with HTN find ways to
transcend the effects of history, restore trust in the health sys-
tem, and form collaborative relationships to foster optimal health
care.
LIMITATIONS
Several limitations were noted in this study. The use of self-
report measures may introduce personal bias. Moreover, the small
convenience sample limits the generalizability of the findings to
other populations in different regions of the U.S. Future studies
could increase the representativeness of the sample by recruit-
ing participants from geographically diverse sites. In addition,
other factors besides trust in the health care provider may impact
medication adherence in Black women with HTN. Additional
research is needed to identify other contributing factors that
are associated with improving medication adherence and blood
pressure control among Black women. Lastly, this was a non-
randomized, cross-sectional study, and causal inferences cannot
be made.
CONCLUSION
In this study, Black women were more likely to be adherent to anti-
hypertensive medications if they had a higher level of trust in their
health care provider. Understanding trust issues in Black women
is essential when considering their disproportionate burden of
HTN. Future research should explore methods for health care
providers to deliver culturally sensitive care and establish trusting
interpersonal relationships with Black women.
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